<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to myasthenia gravis - an autoimmune condition causing muscle weakness, symptoms, treatment, and management strategies.">
    <meta name="keywords" content="myasthenia gravis, MG, muscle weakness, autoimmune neuromuscular, ptosis, diplopia">
    <title>Myasthenia Gravis | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Myasthenia Gravis</h1><p>Autoimmune muscle weakness</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Myasthenia Gravis?</h2>
                <p>Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease that causes weakness in skeletal muscles. The immune system produces antibodies that block or destroy acetylcholine receptors at the neuromuscular junction, disrupting the signal between nerves and muscles.<sup>1</sup></p>

                <h2>Symptoms<sup>2</sup></h2>
                <h3>Ocular Symptoms</h3>
                <ul>
                    <li>Ptosis (drooping eyelids)</li>
                    <li>Diplopia (double vision)</li>
                    <li>Often the first symptoms</li>
                    <li>May remain only ocular in some</li>
                </ul>

                <h3>Generalized Symptoms</h3>
                <ul>
                    <li>Facial muscle weakness</li>
                    <li>Difficulty chewing and swallowing</li>
                    <li>Slurred speech</li>
                    <li>Limb weakness (arms often before legs)</li>
                    <li>Breathing difficulties (in severe cases)</li>
                </ul>

                <h3>Key Characteristic</h3>
                <ul>
                    <li>Weakness worsens with activity</li>
                    <li>Improves with rest</li>
                    <li>Fluctuates throughout day</li>
                    <li>Worse in evening or after exertion</li>
                </ul>

                <h2>Diagnosis</h2>
                <ul>
                    <li>Acetylcholine receptor antibody test</li>
                    <li>MuSK antibody test</li>
                    <li>Edrophonium (Tensilon) test</li>
                    <li>Nerve conduction studies</li>
                    <li>CT or MRI of chest (thymus evaluation)</li>
                </ul>

                <h2>Treatment<sup>3</sup></h2>
                <h3>Medications</h3>
                <ul>
                    <li>Cholinesterase inhibitors (pyridostigmine)</li>
                    <li>Corticosteroids</li>
                    <li>Immunosuppressants (azathioprine, mycophenolate)</li>
                    <li>Newer biologics available</li>
                </ul>

                <h3>Other Treatments</h3>
                <ul>
                    <li>Thymectomy (thymus removal)</li>
                    <li>Plasmapheresis (plasma exchange)</li>
                    <li>Intravenous immunoglobulin (IVIG)</li>
                </ul>

                <h2>Myasthenic Crisis</h2>
                <ul>
                    <li>Life-threatening breathing weakness</li>
                    <li>Requires immediate medical attention</li>
                    <li>May need ventilator support</li>
                    <li>Often triggered by infection or medication changes</li>
                </ul>

                <h2>Living with MG</h2>
                <ul>
                    <li>Plan activities for times of peak strength</li>
                    <li>Take rest breaks throughout day</li>
                    <li>Avoid extreme temperatures</li>
                    <li>Be aware of medications that worsen MG</li>
                    <li>Wear medical alert identification</li>
                    <li>Regular follow-up with neurologist</li>
                </ul>

                <h2>References</h2>
                <ol>
                    <li>Gilhus NE, Tzartos S, Evoli A, et al. Myasthenia gravis. <em>Nat Rev Dis Primers</em>. 2019;5(1):30.</li>
                    <li>Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. <em>Lancet Neurol</em>. 2009;8(5):475-490.</li>
                    <li>Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia gravis. <em>Neurology</em>. 2016;87(4):419-425.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
